Shear Horizontal SAW Biosensor for Real-Time Bioagent Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biosensors face challenges in rapidly and reliably detecting a wide range of biological and chemical agents, including viruses, bacteria, and chemical threats, particularly in complex environments, due to limitations in sensitivity and selectivity.
Innovation Solution
A shear horizontal surface acoustic wave (SH-SAW) biosensor using a lithium tantalate (LiTaO3) wafer with surface-bound ligands that specifically bind to target agents, generating measurable wave patterns for identification and quantification, allowing for real-time detection without pre-processing of samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional biosensors are used for detecting biological agents, then detection capability is provided, but sensitivity and selectivity are insufficient for reliable detection in complex environments
Solution Approach 1:
The patent employs surface acoustic wave (SAW) technology as an intermediary transduction mechanism to convert biological binding events into measurable acoustic signals. The SAW device acts as a mediator between the biological interaction (ligand-analyte binding) and the detection system, enabling highly sensitive and selective detection by measuring changes in wave propagation characteristics when target agents bind to surface-bound ligands.
Solution Approach 2:
The patent replaces conventional detection mechanisms with acoustic wave-based detection. Instead of using traditional optical, electrical, or chemical transduction methods, the invention uses shear horizontal surface acoustic waves to detect binding events. This mechanical wave approach provides enhanced sensitivity and selectivity for detecting biological and chemical agents in complex environments.
2Productivity
If rapid detection of multiple biological and chemical agents is achieved, then detection speed is improved, but detection accuracy and reliability may be compromised
Solution Approach 1:
The patent creates a universal detection platform using SAW technology that can detect multiple types of agents (viruses, bacteria, chemical threats) simultaneously. The system uses surface-bound ligands that can be configured to recognize various target agents, enabling rapid multi-agent detection while maintaining high accuracy through the sensitive acoustic wave measurement mechanism.
Solution Approach 2:
The patent utilizes mechanical vibration in the form of shear horizontal surface acoustic waves to detect binding events. The acoustic waves vibrate at specific frequencies that are highly sensitive to mass changes on the sensor surface, enabling rapid and accurate detection of target agents through frequency shift measurements when analytes bind to ligands.
3Measurement precision
If shear horizontal surface acoustic wave biosensor with surface-bound ligands is used, then sensitivity and selectivity are improved, but device complexity increases
Solution Approach 1:
The patent extracts and utilizes only the essential functional components needed for detection: a piezoelectric substrate with interdigitated transducers that generate and detect shear horizontal surface acoustic waves. By focusing on the core SAW mechanism and removing unnecessary components, the device achieves high sensitivity while maintaining relatively simple structure compared to multi-component biosensor systems.
Solution Approach 2:
The patent changes the operational parameters of the biosensor by using shear horizontal surface acoustic waves at specific frequencies and exploiting the sensitivity of wave propagation to surface mass changes. This parameter-based approach enables high detection sensitivity through acoustic wave frequency and amplitude measurements without requiring complex structural modifications to the sensor device.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The SH-SAW biosensor demonstrates high sensitivity and selectivity for detecting viral agents like Coxsackie virus and Sin Nombre virus, even in complex solutions, with the potential for portable, field-ready applications.
Implementation Method 1
a piezoelectric material, in particular, a lithium tantalate (LiTaO3) wafer is modified to provide on its surface at least one ligand
Implementation Method 2
shear horizontal surface acoustic wave (SH-SAW) biosensor adapted to detect a large number of biological or chemical agents
Implementation Method 3
the ligand becomes bound to a biological agent, the ligand-biological agent will produce a modified wave pattern which can be measured
Data Source
AI summary
Viruses and other bioagents are of high medical and biodefense concern and their detection at concentrations well below the threshold necessary to cause health hazards continues to be a challenge with respect to sensitivity, specificity, and selectivity. Ideally, assays for accurate and real time detection of viral agents and other bioagents would not necessitate any pre-processing of the analyte, which would make them applicable for example to bodily fluids (blood, sputum) and man-made as well as naturally occurring bodies of water (pools, rivers). We describe herein a robust biosensor that combines the sensitivity of surface acoustic waves (SAW) generated at a frequency of 325 MHz with the specificity provided by antibodies and other ligands for the detection of viral agents. In preferred embodiments, a lithium tantalate based SAW transducer with silicon dioxide waveguide sensor platform featuring three test and one reference delay lines was used to adsorb antibodies directed against Coxsackie virus B4 or the negative-stranded category A bioagent Sin Nombre virus (SNV), a member of the genus Hantavirus, family Bunyaviridae, negative-stranded RNA viruses. Rapid detection (within seconds) of increasing concentrations of viral particles was linear over a range of order of magnitude for both viruses, although the sensor was approximately 50×104-fold more sensitive for the detection of SNV. For both pathogens, the sensor's selectivity for its target was not compromised by the presence of confounding Herpes Simplex virus type 1. The biosensor was able to detect SNV at doses lower than the load of virus typically found in a human patient suffering from hantavirus cardiopulmonary syndrome (HCPS). Further, in a proof-of-principle real world application, the SAW biosensor was capable of selectively detecting SNV agents in complex solutions, such as naturally occurring bodies of water (river, sewage effluent) without analyte pre-processing.